ATE478886T1
(en)
|
2003-07-25 |
2010-09-15 |
Idenix Pharmaceuticals Inc |
PURINE NUCLEOSIDES FOR THE TREATMENT OF DISEASES CAUSED BY FLAVIVIDRAE, INCLUDING HEPATITIS C
|
AU2004311702A1
(en)
*
|
2003-12-19 |
2005-07-21 |
Koronis Pharmaceuticals, Inc. |
Mutagenic heterocycles
|
EP1598354A1
(en)
*
|
2004-05-18 |
2005-11-23 |
Vasopharm Biotech GmbH |
Compounds containing a N-heteroaryl moiety linked to fused ring moieties for the inhibition of NAD(P)H oxidases and platelet activation
|
ITMI20041567A1
(en)
*
|
2004-07-30 |
2004-10-30 |
Maycos Italiana Di Comini Miro |
"N-ACYLATED DERIVATIVES OF BICARBOXYLIC ACIDS WITH AMINO ACIDS AND WITH HYDROLYZED VEGETABLE PROTEINS AND THEIR APPLICATION IN COSMETIC, DERMO-PHARMACEUTICAL AND PHARMACEUTICAL PRODUCTS"
|
EP1746099A1
(en)
*
|
2004-12-23 |
2007-01-24 |
DeveloGen Aktiengesellschaft |
Mnk1 or Mnk2 inhibitors
|
ES2524922T3
(en)
|
2005-05-10 |
2014-12-15 |
Intermune, Inc. |
Pyridone derivatives to modulate the stress-activated protein kinase system
|
US7723342B2
(en)
*
|
2005-05-17 |
2010-05-25 |
Schering Corporation |
Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
|
US7750015B2
(en)
|
2005-05-17 |
2010-07-06 |
Schering Corporation |
Nitrogen-containing heterocyclic compounds and methods of use thereof
|
US7737155B2
(en)
*
|
2005-05-17 |
2010-06-15 |
Schering Corporation |
Nitrogen-containing heterocyclic compounds and methods of use thereof
|
CN1947717B
(en)
*
|
2005-10-14 |
2012-09-26 |
卓敏 |
Method for treating neuronal and non-neuronal pain
|
WO2007078013A1
(en)
*
|
2006-01-06 |
2007-07-12 |
Ajinomoto Co., Inc. |
Gelling agent
|
KR20080091814A
(en)
|
2006-01-20 |
2008-10-14 |
쉐링 코포레이션 |
Heterocycles as nicotinic acid receptor agonists for the treatment of dyyslipidemia
|
KR20090047391A
(en)
|
2006-04-07 |
2009-05-12 |
데벨로겐 악틴게젤샤프트 |
Thienopyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions
|
WO2007139497A1
(en)
*
|
2006-05-30 |
2007-12-06 |
Aprea Ab |
Levoglucosenone derivatives for the treatment of disorders such as cancer, autoimmune diseases and heart diseases.
|
US20080009508A1
(en)
*
|
2006-07-10 |
2008-01-10 |
Lucie Szucova |
6,9-Disubstituted Purine Derivatives And Their Use For Treating Skin
|
EP1889847A1
(en)
|
2006-07-10 |
2008-02-20 |
DeveloGen Aktiengesellschaft |
Pyrrolopyrimidines for pharmaceutical compositions
|
EP2164500B1
(en)
*
|
2007-05-25 |
2013-12-04 |
Idogen AB |
The use of zeburaline for the treatment of autoimmune diseases or immune rejection of transplants
|
KR100881137B1
(en)
*
|
2007-08-07 |
2009-02-02 |
충남대학교산학협력단 |
New pig pheromonal compounds, their preparation method and a composite for estrus induction
|
US8304413B2
(en)
|
2008-06-03 |
2012-11-06 |
Intermune, Inc. |
Compounds and methods for treating inflammatory and fibrotic disorders
|
CN103983627A
(en)
|
2008-06-17 |
2014-08-13 |
韩国巴斯德研究所 |
Pyridopyrimidine compounds as anti-tubercular agents
|
AU2009286734A1
(en)
|
2008-08-26 |
2010-03-04 |
Boehringer Ingelheim International Gmbh |
Thienopyrimidines for pharmaceutical compositions
|
KR100883548B1
(en)
*
|
2008-10-15 |
2009-02-13 |
충남대학교산학협력단 |
Pig pheromonal compounds, their preparation method and a composite for estrus induction containing it
|
US8809344B2
(en)
|
2008-10-29 |
2014-08-19 |
Apath, Llc |
Compounds, compositions, and methods for control of hepatitis C viral infections
|
JO2870B1
(en)
|
2008-11-13 |
2015-03-15 |
ميرك شارب اند دوهم كورب |
Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
FR2940611B1
(en)
|
2008-12-30 |
2012-01-13 |
Oreal |
ASSOCIATION OF MONOSACCHARIDES AND ADENOSINE AND ITS USE IN COSMETICS
|
UA112284C2
(en)
*
|
2009-08-07 |
2016-08-25 |
ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі |
5-fluoro-pyrimidinone derivatives
|
PT2462133E
(en)
*
|
2009-08-07 |
2014-12-26 |
Dow Agrosciences Llc |
5-fluoro-2-oxopyrimidine- 1(2h)-carboxylate derivatives as fungicides
|
US8716482B2
(en)
|
2009-09-25 |
2014-05-06 |
Merck Sharp & Dohme Corp. |
Substituted aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes
|
FR2951639B1
(en)
|
2009-10-22 |
2011-11-04 |
Oreal |
USE OF ADENOSINE AND / OR ONE OF ITS DERIVATIVES AS A TREATMENT AGENT FOR HUMAN TRANSPIRATION
|
US20130053433A1
(en)
*
|
2010-01-06 |
2013-02-28 |
The University Of North Carolina At Chapel Hill |
Fatty acid derivatives and analogs of drugs
|
UY33241A
(en)
|
2010-02-26 |
2011-09-30 |
Boehringer Ingelheim Int |
? Tienopyrimidines containing heterocycloalkyl for pharmaceutical compositions ?.
|
EA201201191A1
(en)
|
2010-02-26 |
2013-04-30 |
Бёрингер Ингельхайм Интернациональ Гмбх |
4- [CYCLOALKYLOXY (HETERO) ARYLAMINO] THIENO [2,3-D] PYRIMIDINES THAT HAVE INHIBITING ACTIVITY WITH RESPECT TO MNKL / MNK2 INTENDED FOR PHARMACEUTICAL COMPOSITIONS
|
AR080328A1
(en)
|
2010-02-26 |
2012-03-28 |
Boehringer Ingelheim Int |
TIENOPIRIMIDINES CONTAINING A SUBSTITUTED RENTING GROUP, INHIBITORS OF MNK1 AND / OR MNK2 QUINASES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USE OF THE SAME FOR THE TREATMENT OF METABOLIC DISORDERS SUCH AS DIABETES AND OTHERS
|
EP2608794A4
(en)
*
|
2010-08-26 |
2014-01-22 |
Univ Northeastern |
Methods and compositions for preventing or treating obesity
|
GEP201706656B
(en)
|
2011-11-11 |
2017-04-25 |
Pfizer |
2-thiopyrimidinones
|
US9073960B2
(en)
|
2011-12-22 |
2015-07-07 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
WO2013137832A1
(en)
*
|
2012-03-16 |
2013-09-19 |
Nanyang Technological University |
Myostatin inhibitors
|
USRE48171E1
(en)
|
2012-03-21 |
2020-08-25 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
US9441007B2
(en)
|
2012-03-21 |
2016-09-13 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
EP2861611B1
(en)
|
2012-05-25 |
2016-07-13 |
Janssen Sciences Ireland UC |
Uracyl spirooxetane nucleosides
|
JO3407B1
(en)
|
2012-05-31 |
2019-10-20 |
Eisai R&D Man Co Ltd |
Tetrahydropyrazolopyrimidine Compounds
|
AR092742A1
(en)
|
2012-10-02 |
2015-04-29 |
Intermune Inc |
ANTIFIBROTIC PYRIDINONES
|
JP2015535261A
(en)
*
|
2012-10-29 |
2015-12-10 |
コクリスタル ファーマ,インコーポレイテッド |
Pyrimidine nucleotides and their monophosphate prodrugs for the treatment of viral infections and cancer
|
RS61767B1
(en)
|
2012-12-21 |
2021-05-31 |
Janssen Biopharma Inc |
4'-fluoro-nucleosides, 4'-fluoro-nucleotides and analogs thereof for the treatment of hcv
|
WO2014105844A1
(en)
|
2012-12-28 |
2014-07-03 |
Dow Agrosciences Llc |
N-(substituted)-5-fluoro-4-imino-3-methyl-2-oxo-3,4-dihydropyrimidine-1 (2h)-carboxylate derivatives
|
JP6258969B2
(en)
|
2012-12-28 |
2018-01-10 |
アダマ・マクテシム・リミテッド |
N- (substituted) -5-fluoro-4-imino-3-methyl-2-oxo-3,4-dihydropyrimidine-1 (2H) -carboxamide derivatives
|
US9642368B2
(en)
|
2012-12-31 |
2017-05-09 |
Adama Makhteshim Ltd. |
3-alkyl-5-fluoro-4-substituted-imino-3,4-dihydropyrimidin-2(1H)-one derivatives as fungicides
|
SG10201804835VA
(en)
|
2013-10-11 |
2018-07-30 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
CA2943363A1
(en)
|
2014-04-02 |
2015-10-08 |
Intermune, Inc. |
Anti-fibrotic pyridinones
|
WO2016134042A2
(en)
|
2015-02-18 |
2016-08-25 |
Buck Institute For Research On Aging |
Triazolopyridines and triazolopyrimidines that lower stress-induced p-tau
|
WO2016178113A1
(en)
|
2015-05-05 |
2016-11-10 |
Pfizer Inc. |
2-thiopyrimidinones
|
CN109503587B
(en)
*
|
2017-09-14 |
2022-01-11 |
辽宁利锋科技开发有限公司 |
Anti-tumor effect and application of diheterocyclic triazole nucleoside analogue
|
US12030903B2
(en)
|
2020-02-18 |
2024-07-09 |
Gilead Sciences, Inc. |
Antiviral compounds
|
TWI775313B
(en)
|
2020-02-18 |
2022-08-21 |
美商基利科學股份有限公司 |
Antiviral compounds
|
TWI794742B
(en)
|
2020-02-18 |
2023-03-01 |
美商基利科學股份有限公司 |
Antiviral compounds
|
CA3216162A1
(en)
|
2021-04-16 |
2022-10-20 |
Gilead Sciences, Inc. |
Methods of preparing carbanucleosides using amides
|
CN115501235B
(en)
*
|
2021-08-02 |
2023-11-07 |
中山大学·深圳 |
Application of compound in preparation of medicine for preventing and treating demyelinating diseases
|
WO2023044104A1
(en)
*
|
2021-09-17 |
2023-03-23 |
Emory University |
Phosphoramidates for the treatment of hepatitis b virus
|